Dan Liljenquist, a former Utah state senator, is leading the effort by four large health systems to create a drug company that will keep the rest of the industry from jacking up prices. In other news, the Food and Drug Administration approved a record number of generic drugs in 2017, lawmakers in three states are pushing legislation that would allow promotion of off-label drug uses, and more.
from Kaiser Health News http://ift.tt/2rRrDmd
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment